Jesse T. Jacob
Accounting for the presence of multiple, concurrent central lines when calculating central line-associated bloodstream infections, or CLABSIs, lowered CLABSI rates by 25% over the course of 18 months in the ICUs at two hospitals, researchers reported in Infection Control & Hospital Epidemiology.
In the study, the researchers calculated CLABSI rates for ICU and non-ICU patients using a modified denominator — which counted the number of central lines in one patient in 1 day as the number of line days — and the standard National Healthcare Safety Network (NHSN) denominator, which counts only the number of days when any central line is present.
“Current surveillance definitions for CLABSI may not accurately assess the intrinsic risk of central lines, and modifications to the definition should be considered,” Jesse T. Jacob, MD, associate professor of medicine in the division of infectious diseases at the Emory University School of Medicine, told Infectious Disease News. “Removal of unnecessary central lines should remain a priority.”
For the study, Jacob and colleagues retrospectively identified all adult patients with central lines hospitalized at two medical centers from December 2009 to June 2011. Patients who had multiple concurrent central lines were more likely to have a dialysis catheter, have a longer admission, to be in an ICU and to have a CLABSI, they reported.
Among 18,521 hospital admissions, there were 239 CLABSIs (ICU, 105; non-ICU 134) in 156,574 central line days. When the modified denominator was used, there was a 25% lower CLABSI rate in ICU patients (1.95 vs. 1.47 per 1,000 line days) and a 6% lower rate in non-ICU patients (1.30 vs 1.22 per 1,000 line days), Jacob and colleagues reported.
Findings also indicated that the presence of multiple concurrent central lines may be an indicator for severity of illness, they said.
In the past, reducing central venous catheters, using silver-plated nylon dressings for catheters, and using chlorohexidine gluconate wipes for patient hygiene have been shown to reduce CLABSI rates.
“We have made great strides in reduction, but much work needs to be done,” Jacob said. “Risk adjustment beyond the basic factors currently used in CDC’s modeling is an area of active research since hospitals caring for more complex patients may have higher CLABSI rates.” – by Eamon Dreisbach
Couk J, et al. Infect Control Hosp Epidemiol. 2019;doi:10.1017/ice.2019.180.
Disclosures: Jacob reports no relevant financial disclosures. Please see the full study for the other authors’ relevant financial disclosures.